Article: Pfizer to launch generic version of Norvasc.(Brief article)

Article: Teva updates on generic Biaxin.(launched a generic ...
Pharma Marketletter;  July 3, 2006 ;     614 words ...Israeli drugmaker Teva Pharmaceutical Industries says that it launched a generic version of US health care major Abbott Laboratories' Biaxin (clarithromycin) XL Filmtabs on June 23, following the decision rendered ...

Article: Generic version of Ortho-Cyclen tablets ...
Women's Health Weekly;  November 7, 2002 ;     700+ words ... ... announced that the U.S. Food and Drug Administration (FDA) has approved its application to manufacture and market a generic version of Ortho-McNeil Pharmaceutical, Inc.'s, Ortho-Cyclen tablets oral contraceptive 28-day regimen. The company ...

Article: Generics Suppliers Take Their Case to Court.(court battle of ...
Chain Drug Review;  September 25, 2000 ;     700+ words ... ... Drug Administration approval of a generic version of Taxol became further entangled ... Corp., which hopes to bring out a generic version, and American BioScience Inc ... to Impax' filing of an ANDA for a generic version of Tricor (fenofibrate capsules ...

Article: Barr Wins Fight to Market Generic Version of ...
Chain Drug Review;  August 27, 2001 ;     700+ words ... ... approval of Barr Laboratories Inc.'s generic version of Prozac, Eli Lilly and Co ... weeks in advance that the arrival of a generic version of Prozac on pharmacy shelves was ... company filed its application for a generic version in December 1995 and was sued by Lilly ...

Article: Ranbaxy products. (RXs).(Ranbaxy Laboratories Ltd. to launch ...
Chain Drug Review;  January 20, 2003 ;     700+ words ...Ranbaxy Laboratories Ltd. will launch a generic version of Accutane, Roche Holding AG's antiacne drug. The company, with United States operations based in Princeton, N.J., has ...

Article: States to settle suits against Bristol-Myers. (Industry ...
Medical Marketing & Media;  February 1, 2003 ;     656 words ... ... Puerto Rico that it allegedly used illegal tactics to keep a generic version of the anti-anxiety drug BuSpar off the market. The company ... made the same charges against BMS' actions in blocking a generic version of Taxol. Under the settlement, the company will pay ...

Article: GENERICS.(Watson Pharmaceuticals seeking approval for ...
Chemical Market Reporter;  November 27, 2000 ;     614 words ...GENERICS--Watson Pharmaceuticals says it expects a delay in FDA approval for its generic version of Bristol-Myers Squibb's BuSpar (buspirone). Watson had expected FDA approval last week, but says the approval process ...